Drug Discovery Outsourcing Market Overview

The report is titled ‘Drug Discovery Outsourcing Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the drug discovery outsourcing market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The drug discovery outsourcing market is expected to grow at a significant rate in the near future.

The global drug discovery outsourcing market in 2020 is estimated for more than US$ 3.1 Bn and expected to reach a value of US$ 5.8 Bn by 2028 with a significant CAGR of 8.5%.

Drug Discovery Outsourcing Market Definition

Contract research organizations are not the only scientific bodies well-equipped to aid pharmaceutical and biotechnology companies with their drug discovery efforts. Many pharmaceutical companies have active collaborations in academia because they realize that well-funded research teams working in small numbers provide greater flexibility and increase productivity against the cost of funding. Moreover, smaller teams tend to communicate better and this can have the added benefit of avoiding obstacles and improving the efficiency and time of the drug discovery process.

Drug Discovery Outsourcing Market Dynamics

In a 2011 survey of academic drug discovery research published in Nature Reviews Drug Discovery, scientists from the University of North Carolina found that in a sample population of 78 US drug discovery centers within academia or in the non-profit research sector, over three-quarters of drug candidates pursued were in the oncology therapeutic area. The centers surveyed were looking at a range of ‘druggable’ targets including protein kinases and G protein-coupled receptors. Most academic or non-profit research centers reported capabilities for in vitro cell-based primary assay development, target identification, and cellular biology. These results come at a time when the US National Institutes of Health (NIH) is trailing an ambitious agenda for ‘drug rescue and repurposing’. Under this scheme, information on the pharmacology, formulation, and dosing profiles of previously approved or abandoned drugs could be used to test new clinical hypotheses. This would save money and accelerate the process of making therapies available to patients.

Drug Discovery Outsourcing Market Segmentation

The drug discovery outsourcing market includes segments such as application, technology, product, and end-use. The global drug discovery outsourcing market is segmented on the basis of the sector by region. The sector segment further divided into four other categories such as chemistry services, biology services, lead optimization, and lead identification & screening.

Drug Discovery Outsourcing Market Key Players

Global Drug Discovery Outsourcing market is mainly dominated by Albany Molecular Research (AMRI), Aptuit, Charles River Laboratories, Covance (Acquired by Laboratory Corporation of America), Cyprotex, Domainex, Evotec, GenScript, Pharmaceutical Product Development (PPD), Quintiles, Selcia, Viva Biotech, WIL Research Laboratories, WuXi Apptec.

Drug Discovery Outsourcing Market Regional Overview Analysis

On the basis of region, the global Drug Discovery Outsourcing market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America Drug Discovery Outsourcing market is expected to be the most dominating market throughout the forecast period due to the increasing number of genetic pharmaceutical companies and research institutes in the U.S. Whereas, Europe will maintain its second-largest position with Germany and U.K being the most attractive markets within the region.

MMC Overview on Drug Discovery Outsourcing Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.

A research report on the Drug Discovery Outsourcing market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth include (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Drug Discovery Outsourcing

•    Advantage of Drug Discovery Outsourcing

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at a regional level and in major countries globally for providing regional insights into the product segment in the report. This helps our clients to make an informed decision.

A mix of top-down and bottom-up approach is followed to arrive at and validate our market value estimations. For a product segment wherein one/two manufacturer(s) dominates the market, its product sales, previous growth rates, and market expansion plans are considered to generate market share in the global market.

1.    Global Drug Discovery Outsourcing Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Drug Discovery Outsourcing Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Drug Discovery Outsourcing Market Snapshot

2.4.    Global Drug Discovery Outsourcing Market Size and Forecast, 2019–2027

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2019–2027)

2.5.    Global Drug Discovery Outsourcing Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Drug Discovery Outsourcing Market, By Sector

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Sector

3.1.2.    BPS Analysis, By Sector

3.2.    Market Revenue (US$Mn) Forecast, By Sector

3.2.1.    Chemistry Services

3.2.2.    Biology Services

3.2.3.    Lead Optimization

3.2.4.    Lead Identification & Screening

3.3.    Global Drug Discovery Outsourcing Market Attractiveness Index, By Sector

4.    Global Drug Discovery Outsourcing Market, By Region

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Region

4.1.2.    BPS Analysis, By Region

4.2.    Market Revenue (US$Mn) Forecast, By Region

4.2.1.    North America

4.2.2.    Latin America

4.2.3.    Europe

4.2.4.    Asia Pacific

4.2.5.    Middle East

4.2.6.    Africa

4.3.    Global Drug Discovery Outsourcing Market Attractiveness Index, By Region

5.    North America Drug Discovery Outsourcing Market Analysis and Forecast, 2019–2027

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Country

5.1.2.    BPS Analysis, By Country

5.2.    Market Revenue (US$Mn) Forecast, By Country

5.2.1.    U.S. Drug Discovery Outsourcing Market

5.2.2.    Canada Drug Discovery Outsourcing Market

5.3.    North America Drug Discovery Outsourcing Market, By Sector

5.3.1.    Chemistry Services

5.3.2.    Biology Services

5.3.3.    Lead Optimization

5.3.4.    Lead Identification & Screening

5.4.    North America Drug Discovery Outsourcing Market Attractiveness Index

5.4.1.    By Country

5.4.2.    By Sector

6.    Latin America Drug Discovery Outsourcing Market Analysis and Forecast, 2019–2027

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Country

6.1.2.    BPS Analysis, By Country

6.2.    Market (US$Mn) Forecast, By Country

6.2.1.    Brazil Drug Discovery Outsourcing Market

6.2.2.    Mexico Drug Discovery Outsourcing Market

6.2.3.    Argentina Drug Discovery Outsourcing Market

6.2.4.    Rest of Latin America Drug Discovery Outsourcing Market

6.3.    Latin America Drug Discovery Outsourcing Market, By Sector

6.3.1.    Chemistry Services

6.3.2.    Biology Services

6.3.3.    Lead Optimization

6.3.4.    Lead Identification & Screening

6.4.    Attractiveness Index

6.4.1.    By Country

6.4.2.    By Sector

7.    Europe Drug Discovery Outsourcing Market Analysis and Forecast, 2019–2027

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market (US$Mn) Forecast, By Country

7.2.1.    U.K. Drug Discovery Outsourcing Market

7.2.2.    Germany Drug Discovery Outsourcing Market

7.2.3.    Italy Drug Discovery Outsourcing Market

7.2.4.    France Drug Discovery Outsourcing Market

7.2.5.    Spain Drug Discovery Outsourcing Market

7.2.6.    Russia Drug Discovery Outsourcing Market

7.2.7.    Poland Drug Discovery Outsourcing Market

7.2.8.    BENELUX Drug Discovery Outsourcing Market

7.2.9.    NORDIC Drug Discovery Outsourcing Market

7.2.10.    Rest of Europe Drug Discovery Outsourcing Market

7.3.    Europe Drug Discovery Outsourcing Market, By Sector

7.3.1.    Chemistry Services

7.3.2.    Biology Services

7.3.3.    Lead Optimization

7.3.4.    Lead Identification & Screening

7.4.    Europe Drug Discovery Outsourcing Market Attractiveness Index

7.4.1.    By Country

7.4.2.    By Sector

8.    Asia Pacific Drug Discovery Outsourcing Market Analysis and Forecast, 2019–2027

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    China Drug Discovery Outsourcing Market

8.2.2.    India Drug Discovery Outsourcing Market

8.2.3.    Japan Drug Discovery Outsourcing Market

8.2.4.    Australia and New Zealand Drug Discovery Outsourcing Market

8.2.5.    South Korea Drug Discovery Outsourcing Market

8.2.6.    ASEAN Drug Discovery Outsourcing Market

8.2.7.    Rest of Asia Pacific Drug Discovery Outsourcing Market

8.3.    Asia Pacific Drug Discovery Outsourcing Market, By Sector

8.3.1.    Chemistry Services

8.3.2.    Biology Services

8.3.3.    Lead Optimization

8.3.4.    Lead Identification & Screening

8.4.    Asia Pacific Drug Discovery Outsourcing Market Attractiveness Index

8.4.1.    By Country

8.4.2.    By Sector

9.    Middle East Drug Discovery Outsourcing Market, By Region

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    GCC Countries Drug Discovery Outsourcing Market

9.2.2.    Israel Drug Discovery Outsourcing Market

9.2.3.    Oman Drug Discovery Outsourcing Market

9.2.4.    Rest of Middle East Drug Discovery Outsourcing Market

9.3.    Middle East Drug Discovery Outsourcing Market, By Sector

9.3.1.    Chemistry Services

9.3.2.    Biology Services

9.3.3.    Lead Optimization

9.3.4.    Lead Identification & Screening

9.4.    Middle East Drug Discovery Outsourcing Market Attractiveness Index

9.4.1.    By Country

9.4.2.    By Sector

10.    Africa Drug Discovery Outsourcing Market, By Region

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    South Africa Drug Discovery Outsourcing Market

10.2.2.    Egypt Drug Discovery Outsourcing Market

10.2.3.    North Africa Drug Discovery Outsourcing Market

10.2.4.    Rest of Africa Drug Discovery Outsourcing Market

10.3.    Africa Drug Discovery Outsourcing Market, By Sector

10.3.1.    Chemistry Services

10.3.2.    Biology Services

10.3.3.    Lead Optimization

10.3.4.    Lead Identification & Screening

10.4.    Africa Drug Discovery Outsourcing Market Attractiveness Index

10.4.1.    By Country

10.4.2.    By Sector

11.    Recommendation

11.1.    Market Strategy

12.    Competitive Landscape

12.1.    Competition Dashboard

12.2.    List and Company Overview of Global Key Players

12.3.    Company Profiles

12.3.1.    Albany Molecular Research (AMRI)

12.3.1.1.    Company Overview

12.3.1.2.    Financial Overview

12.3.1.3.    Product Portfolio

12.3.1.4.    Key Developments

12.3.1.5.    Business Strategies

12.3.2.    Aptuit

12.3.3.    Charles River Laboratories

12.3.4.    Covance (Acquired by Laboratory Corporation of America)

12.3.5.    Cyprotex

12.3.6.    Domainex

12.3.7.    Evotec

12.3.8.    GenScript

12.3.9.    Pharmaceutical Product Development (PPD)

12.3.10.    Quintiles

12.3.11.    Selcia

12.3.12.    Viva Biotech

12.3.13.    WIL Research Laboratories

12.3.14.    WuXi Apptec

13.    Acronyms